NEKTAR THERAPEUTICS
Public company- Headquarters
- SAN FRANCISCO, California
- Ticker
- NKTR
- CIK
- 0000906709
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
No executive changes on record.
Related companies
Same industry and state, with recent events.
- ACADIA PHARMACEUTICALS INC
Executive Vice President, Head of Research and Development departs: Elizabeth H.Z. Thompson, Ph.D.
- KYNTRA BIO, INC.
Class III director appointed: Andrew E. Singer, MBA
- BIOMARIN PHARMACEUTICAL INC
WARN notice: Novato, CA
- CORCEPT THERAPEUTICS INC
President of Corcept Endocrinology departs: Sean Maduck
layoffs from Jun 16, 2023
WARN noticeWARN notice: CA
Nektar Therapeutics filed a WARN notice with the California WARN list on Apr 17, 2023 covering 72 workers. The layoffs take effect on Jun 16, 2023.
Source: California WARN list, filed Apr 17, 2023Site: CA
Workers affected: 72
layoffs from Jun 26, 2022
WARN noticeWARN notice: Huntsville, AL
Nektar Therapeutics filed a WARN notice with the Alabama WARN list on Apr 29, 2022 covering 72 workers in Huntsville. The layoffs take effect on Jun 26, 2022.
Source: Alabama WARN list, filed Apr 29, 2022Site: Huntsville, AL
Workers affected: 72
layoffs from Jun 26, 2022
WARN noticeWARN notice: CA
Nektar Therapeutics filed a WARN notice with the California WARN list on Apr 26, 2022 covering 337 workers. The layoffs take effect on Jun 26, 2022.
Source: California WARN list, filed Apr 26, 2022Site: CA
Workers affected: 337
Last verified Nov 8, 2026